Chagas disease

The Lancet

Volumn 375, Issue 9723, 2010, Pages 1388-1402

  Rassi Jr , Anis ^a   Rassi, Anis ^a   Marin Neto, José Antonio ^b  

^a Anis Rassi Hospital   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; NIFURTIMOX;

BLOOD DONOR; CHAGAS DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DEFIBRILLATOR; DISEASE COURSE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; LIFE CYCLE; NONHUMAN; PARASITE TRANSMISSION; PATHOGENESIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SOUTH AND CENTRAL AMERICA; TRYPANOSOMA CRUZI;

EID: 77950824213     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60061-X     Document Type: Review

References (132)

1. Hotez P.J., Molyneux D.H., Fenwick A., et al. Control of neglected tropical diseases. N Engl J Med 357 (2007) 1018-1027
2. Mathers C.D., Ezzati M., and Lopez A.D. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 1 (2007) e114
3. Moncayo A., and Silveira A.C. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 104 suppl 1 (2009) 17-30
4. Chagas C. Nova tripanozomiase humana. Estudos sobre a morfolojía e o ciclo evolutivo de Schizotrypanum cruzi n. gen., n. sp., ajente etiolójico de nova entidade morbida do homen. Mem Inst Oswaldo Cruz 1 (1909) 159-218 (in Portuguese).
5. Aufderheide A.C., Salo W., Madden M., et al. A 9,000-year record of Chagas disease. Proc Natl Acad Sci USA 101 (2004) 2034-2039
6. Bernstein R.E. Darwin's illness: Chagas disease resurgens. J R Soc Med 77 (1984) 608-609
7. Deane L.M. Animal reservoirs of Trypanosoma cruzi in Brazil. Rev Bras Malariol Doencas Trop 16 (1964) 27-48
8. Lent H., and Wygodzinsky P. Revision of the Triatominae (Hemiptera, Reduviidae), and their significance as vector of Chagas disease. Bull Am Mus Nat History 163 (1979) 123-520
9. Galvão C., Carcavallo R., Rocha D.S., and Jurberg J. A checklist of the current valid species of the subfamily Triatominae Jeannel, 1919 (Hemiptera, Reduviidae) and their geographical distribution, with nomenclatural and taxonomic notes. Zootaxa 202 (2003) 1-36
10. WHO. Control of Chagas disease. Second report of the WHO Expert Committee. Technical report series no 905 (2002), World Health Organization, Geneva
11. Zeledón R., and Rabinovich J.E. Chagas' disease: an ecological appraisal with special emphasis on its insect vectors. Annu Rev Entomol 26 (1981) 101-133
12. Schmunis G.A. Prevention of transfusional Trypanosoma cruzi infection in Latin America. Mem Inst Oswaldo Cruz 94 suppl 1 (1999) 93-101
13. Bern C., Montgomery S.P., Katz L., Caglioti S., and Stramer S.L. Chagas disease and the US blood supply. Curr Opin Infect Dis 21 (2008) 476-482
14. Russomando G., de Tomassone M.M., de Guillen I., et al. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg 59 (1998) 487-491
15. Torrico F., Alonso-Vega C., Suarez E., et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg 70 (2004) 201-209
16. Villalba R., Fornés G., Alvarez M.A., et al. Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report. Clin Infect Dis 14 (1992) 594-595
17. Cimo P.L., Luper W.E., and Scouros M.A. Transfusion-associated Chagas' disease in Texas: report of a case. Tex Med 89 (1993) 48-50
18. Leiby D.A., Lenes B.A., Tibbals M.A., and Tames-Olmedo M.T. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 341 (1999) 1237-1239
19. US Centers for Disease Control and Prevention. Chagas disease after organ transplantation-Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 55 (2006) 798-800
20. Pereira K.S., Schmidt F.L., Guaraldo A.M., Franco R.M., Dias V.L., and Passos L.A. Chagas disease as a foodborne illness. J Food Prot 72 (2009) 441-446
21. Rassi A., Rassi Jr. A., Rassi S.G., et al. Doença de Chagas. In: Lopes A.C. (Ed). Tratado de clínica médica. 2nd edn. (2009), Editora Roca, São Paulo 4123-4134
22. Brener Z. Life cycle of Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 13 (1971) 171-178
23. Tyler K.M., and Engman D.M. The life-cycle of Trypanosoma cruzi. In: Tyler K.M., and Miles M.A. (Eds). American trypanosomiasis. World class parasites vol 7 (2003), Kluwer Academic Publishers, Boston, MA 1-11
24. Macedo A.M., Machado C.R., Oliveira R.P., and Pena S.D. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease. Mem Inst Oswaldo Cruz 99 (2004) 1-12
25. Manoel-Caetano F.S., and Silva A.E. Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease. Cad Saude Publica 23 (2007) 2263-2274
26. Memórias do Instituto Oswaldo Cruz. Recommendations from a satellite meeting. Mem Inst Oswaldo Cruz 94 suppl 1 (1999) 429-432
27. Di Noia J.M., Buscaglia C.A., De Marchi C.R., Almeida I.C., and Frasch A.C. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. J Exp Med 195 (2002) 401-413
28. Freitas J.M., Lages-Silva E., Crema E., Pena S.D., and Macedo A.M. Real time PCR strategy for the identification of major lineages of Trypanosoma cruzi directly in chronically infected human tissues. Int J Parasitol 35 (2005) 411-417
29. Brisse S., Dujardin J.C., and Tibayrenc M. Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. Mol Biochem Parasitol 111 (2000) 95-105
30. Freitas J.M., Augusto-Pinto L., Pimenta J.R., et al. Ancestral genomes, sex, and the population structure of Trypanosoma cruzi. PLoS Pathog 2 (2006) e24
31. El-Sayed N.M., Myler P.J., Bartholomeu D.C., et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309 (2005) 409-415
32. Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 98 (2003) 577-591
33. Aguilar V.H.M., Abad-Franch F., Racines V.J., and Paucar C.A. Epidemiology of Chagas disease in Ecuador. A brief review. Mem Inst Oswaldo Cruz 94 suppl 1 (1999) 387-393
34. Organizacion Panamericana de la Salud. Estimacion cuantitativa de la enfermedad de Chagas en las Americas (2006), Organizacion Panamericana de la Salud, Montevideo, Uruguay (in Spanish).
35. Schmuñis G.A. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 31 (1991) 547-557
36. Schmunis G.A. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 102 suppl 1 (2007) 75-85
37. Bern C., and Montgomery S.P. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49 (2009) e52-e54
38. Gascon J., Bern C., and Pinazo M.J. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop (2009) 10.1016/j.actatropica.2009.07.019 published online July 29.
39. Guerri-Guttenberg R.A., Grana D.R., Ambrosio G., and Milei J. Chagas cardiomyopathy: Europe is not spared!. Eur Heart J 29 (2008) 2587-2591
40. Laranja F.S., Dias E., Nobrega G., and Miranda A. Chagas' disease; a clinical, epidemiologic, and pathologic study. Circulation 14 (1956) 1035-1060
41. Dias J.C.P. Acute Chagas' disease. Mem Inst Oswaldo Cruz 79 suppl (1984) 85-91
42. Rassi A., and Luquetti A.O. Therapy of Chagas disease. In: Wendel S., Brener Z., Camargo M.E., and Rassi A. (Eds). Chagas disease (American Trypanosomiasis): its impact on transfusion and clinical medicine (1992), ISBT Brazil, São Paulo 237-247
43. Pinto A.Y., Ferreira Jr. A.G., Valente Vda C., Harada G.S., and Valente S.A. Urban outbreak of acute Chagas disease in Amazon region of Brazil: four-year follow-up after treatment with benznidazole. Rev Panam Salud Publica 25 (2009) 77-83
44. Dias J.C.P. Natural history of Chagas' disease. Arq Bras Cardiol 65 (1995) 359-366 (in Portuguese).
45. Braz L.M., Amato Neto V., and Okay T.S. Reactivation of Trypanosoma cruzi infection in immunosuppressed patients: contributions for the laboratorial diagnosis standardization. Rev Inst Med Trop Sao Paulo 50 (2008) 65-66
46. Andrade Z.A. Immunopathology of Chagas disease. Mem Inst Oswaldo Cruz 94 suppl 1 (1999) 71-80
47. Abrahamsohn I.A., and Coffman R.L. Trypanosoma cruzi: IL-10, TNF, IFN-γ, and IL-12 regulate innate and acquired immunity to infection. Exp Parasitol 84 (1996) 231-244
48. Aliberti J.C., Cardoso M.A., Martins G.A., Gazzinelli R.T., Vieira L.Q., and Silva J.S. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 64 (1996) 1961-1967
49. Silva J.S., Aliberti J.C., Martins G.A., Souza M.A., Souto J.T., and Pádua M.A. The role of IL-12 in experimental Trypanosoma cruzi infection. Braz J Med Biol Res 31 (1998) 111-115
50. Martins G.A., Vieira L.Q., Cunha F.Q., and Silva J.S. Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect Immun 67 (1999) 3864-3871
51. Silva J.S., Twardzik D.R., and Reed S.G. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). J Exp Med 174 (1991) 539-545
52. Reed S.G., Brownell C.E., Russo D.M., Silva J.S., Grabstein K.H., and Morrissey P.J. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J Immunol 153 (1994) 3135-3140
53. Chandra M., Tanowitz H.B., Petkova S.B., et al. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int J Parasitol 32 (2002) 897-905
54. Gutierrez F.R., Mineo T.W., Pavanelli W.R., Guedes P.M., and Silva J.S. The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 104 suppl 1 (2009) 236-245
55. Tarleton R.L. Trypanosoma cruzi and Chagas disease: cause and effect. In: Tyler K.M., and Miles M.A. (Eds). World class parasites: American trypanosomiasis vol 7 (2003), Kluwer Academic Publishers, Boston, MA 107-116
56. Kierszenbaum F. Mechanisms of pathogenesis in Chagas disease. Acta Parasitol 52 (2007) 1-12
57. Bonney K.M., and Engman D.M. Chagas heart disease pathogenesis: one mechanism or many?. Curr Mol Med 8 (2008) 510-518
58. Tarleton R.L., and Zhang L. Chagas disease etiology: autoimmunity or parasite persistence?. Parasitol Today 15 (1999) 94-99
59. Soares M.B., Pontes-De-Carvalho L., and Ribeiro-Dos-Santos R. The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An Acad Bras Cienc 73 (2001) 547-559
60. Marin-Neto J.A., Cunha-Neto E., Maciel B.C., and Simoes M.V. Pathogenesis of chronic Chagas heart disease. Circulation 115 (2007) 1109-1123
61. Minoprio P. Parasite polyclonal activators: new targets for vaccination approaches?. Int J Parasitol 31 (2001) 588-591
62. Cunha-Neto E., Bilate A.M., Hyland K.V., Fonseca S.G., Kalil J., and Engman D.M. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39 (2006) 41-54
63. Gironès N., Rodríguez C.I., Carrasco-Marín E., Hernáez R.F., de Rego J.L., and Fresno M. Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease. J Clin Invest 107 (2001) 985-993
64. Dos Reis G.A., Freire-de-Lima C.G., Nunes M.P., and Lopes M.F. The importance of aberrant T-cell responses in Chagas disease. Trends Parasitol 21 (2005) 237-243
65. Acquatella H. Echocardiography in Chagas heart disease. Circulation 115 (2007) 1124-1131
66. Andrade Z.A. Mechanisms of myocardial damage in Trypanosoma cruzi infection. Ciba Found Symp 99 (1983) 214-233
67. Rassi Jr. A., Rassi A., and Little W.C. Chagas heart disease. Clin Cardiol 23 (2000) 883-889
68. Rassi Jr. A., Rassi A., and Marin-Neto J.A. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz 104 suppl 1 (2009) 152-158
69. Rossi M.A. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am Heart J 120 (1990) 233-236
70. Marin-Neto J.A., Marzullo P., Marcassa C., et al. Myocardial perfusion defects in chronic Chagas' disease as detected by thallium-201 scintigraphy. Am J Cardiol 69 (1992) 780-784
71. Köberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol 6 (1968) 63-116
72. Rassi A., Rassi Jr. A., and Rassi G.G. Fase aguda da doença de Chagas. In: Brener Z., Andrade Z.A., and Barral-Netto M. (Eds). Trypanosoma cruzi e doença de Chagas. 2nd edn. (2000), Guanabara Koogan, Rio de Janeiro 231-245 (in Portuguese).
73. Bittencourt A.L. Congenital Chagas disease. Am J Dis Child 130 (1976) 97-103
74. Freilij H., and Altcheh J. Congenital Chagas' disease: diagnostic and clinical aspects. Clin Infect Dis 21 (1995) 551-555
75. Marin-Neto J.A., Simões M.V., and Sarabanda A.V. Chagas heart disease. Arq Bras Cardiol 72 (1999) 247-280
76. Marin-Neto J.A., Rassi Jr. A., Maciel B.C., Simões M.V., and Schmidt A. Chagas heart disease. In: Yusuf S., Cairns J.A., Camm A.J., Fallen E.L., and Gersh B.J. (Eds). Evidence-based cardiology. 3rd edn. (2010), BMJ Books, London 823-841
77. Miles M.A., Feliciangeli M.D., and de Arias A.R. American trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategies. BMJ 326 (2003) 1444-1448
78. Campbell D.A., Westenberger S.J., and Sturm N.R. The determinants of Chagas disease: connecting parasite and host genetics. Curr Mol Med 4 (2004) 549-562
79. de Rezende J.M., and Luquetti A.O. Chagasic megavisceras. Chagas' disease and the nervous system. Scientific publication, no 547 (1994), Pan American Health Organization, Washington, DC 149-171
80. Brandalise N.A., Andreollo N.A., Leonardi L.S., and Neto F.C. Carcinoma associated with Chaga's megaesophagus. Rev Col Bras Cir 12 (1985) 196-199 (in Portuguese).
81. Garcia S.B., Aranha A.L., Garcia F.R., et al. A retrospective study of histopathological findings in 894 cases of megacolon: what is the relationship between megacolon and colonic cancer?. Rev Inst Med Trop Sao Paulo 45 (2003) 91-93
82. Rassi Jr. A., Gabriel Rassi A., Gabriel Rassi S., et al. Ventricular arrhythmia in Chagas disease. Diagnostic, prognostic, and therapeutic features. Arq Bras Cardiol 65 (1995) 377-387 (in Portuguese).
83. Mendoza I., Camardo J., Moleiro F., et al. Sustained ventricular tachycardia in chronic chagasic myocarditis: electrophysiologic and pharmacologic characteristics. Am J Cardiol 57 (1986) 423-427
84. Sosa E., Scanavacca M., d'Avila A., et al. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia. J Cardiovasc Electrophysiol 9 (1998) 229-239
85. D'Avila A., Splinter R., Svenson R.H., et al. New perspectives on catheter-based ablation of ventricular tachycardia complicating Chagas disease: experimental evidence of the efficacy of near infrared lasers for catheter ablation of Chagas VT. J Interv Card Electrophysiol 7 (2002) 23-38
86. Freitas H.F., Chizzola P.R., Paes A.T., et al. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas heart disease. Int J Cardiol 102 (2005) 239-247
87. Oliveira J.S.M., Araujo R.R.C., Navarro M.A., et al. Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol 52 (1983) 147-151
88. Carod-Artal F.J., Vargas A.P., Horan T.A., et al. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 36 (2005) 965-970
89. Rassi Jr. A., Rassi S.G., Rassi A.G., et al. Sudden death in Chagas disease. Arq Bras Cardiol 76 (2001) 75-96
90. Kuschnir E., Sgammini H., Castro R., Evequoz C., Ledesma R., and Brunetto J. Evaluation of cardiac function by radioisotopic angiography, in patients with chronic Chagas cardiopathy. Arq Bras Cardiol 45 (1985) 249-256 (in Spanish).
91. Carrasco H.A., Barboza J.S., Inglessis G., Fuenmayor A., and Molina C. Left ventricular cineangiography in Chagas' disease: detection of early myocardial damage. Am Heart J 104 (1982) 595-602
92. Ministério da Saúde. Secretaria de Vigilância em Saúde. Brazilian Consensus on Chagas disease. Rev Soc Bras Med Tropy 38 suppl 3 (2005) 7-29 (in Portuguese).
93. Fiorelli A.I., Stolf N.A., Honorato R., et al. Later evolution after cardiac transplantation in Chagas' disease. Transplant Proc 37 (2005) 2793-2798
94. Altclas J., Sinagra A., Dictar M., et al. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant 36 (2005) 123-129
95. Sartori A.M., Ibrahim K.Y., Westphalen E.N., et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 10 (2007) 31-50
96. Vaidian A.K., Weiss L.M., and Tanowitz H.B. Chagas' disease and AIDS. Kinetoplastid Biol Dis 3 (2004) 2
97. Gomes Y.M., Lorena V.M., and Luquetti A.O. Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?. Mem Inst Oswaldo Cruz 104 suppl 1 (2009) 115-121
98. Russomando G., Almirón M., Candia N., Franco L., Sánchez Z., and de Guillen I. Implementation and evaluation of a locally sustainable system of prenatal diagnosis to detect cases of congenital Chagas disease in endemic areas of Paraguay. Rev Soc Bras Med Trop 38 suppl 2 (2005) 49-54 (in Spanish).
99. Mora M.C., Negrette O.S., Marco D., et al. Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology. J Parasitol 91 (2005) 1468-1473
100. Diez C.N., Manattini S., Zanuttini J.C., Bottasso O., and Marcipar I. The value of molecular studies for the diagnosis of congenital Chagas disease in northeastern Argentina. Am J Trop Med Hyg 78 (2008) 624-627
101. Britto C.C. Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem Inst Oswaldo Cruz 104 suppl 1 (2009) 122-135
102. Forichon E. Contribution aux estimations de morbidité et de mortalité dans la maladie de Chagas. Thesis, Université Paul-Sabatier, Toulouse, France, 1974 (in French).
103. Ianni B.M., Arteaga E., Frimm C.C., Barretto A.P., and Mady C. Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form. Arq Bras Cardiol 771 (2001) 59-62
104. Garzon S.A., Lorga A.M., and Nicolau J.C. Electrocardiography in Chagas' heart disease. Sao Paulo Med J 113 (1995) 802-813
105. Rassi Jr. A., Rassi A., Little W.C., et al. Development and validation of a risk score for predicting mortality in Chagas' heart disease. N Engl J Med 355 (2006) 799-808
106. Rocha M.O., and Ribeiro A.L. A risk score for predicting death in Chagas heart disease. N Engl J Med 355 (2006) 2488-2489
107. Rassi Jr. A., Waktare J., Rassi S.G., et al. Chagas heart disease: long term prognostic significance of nonsustained ventricular tachycardia and left ventricular dysfunction. Pacing Clin Electrophysiol 22 part II (1999) 862 (abstr).
108. Rassi Jr. A., Rassi A., and Rassi S.G. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 115 (2007) 1101-1108
109. Bern C., Montgomery S.P., Herwaldt B.L., et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 298 (2007) 2171-2181
110. Andrade A.L., Zicker F., Oliveira R.M., et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348 (1996) 1407-1413
111. Estani S.S., Segura E.L., Ruiz A.M., et al. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 59 (1998) 526-529
112. Viotti R., Vigliano C., Lococo B., et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 144 (2006) 724-734
113. Fabbro D.L., Streiger M.L., Arias E.D., et al. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution. Rev Soc Bras Med Trop 40 (2007) 1-10
114. Viotti R., Vigliano C., Lococo B., et al. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev Anti Infect Ther 7 (2009) 157-163
115. Marin-Neto J.A., Rassi Jr. A., Morillo C.A., et al., on behalf of BENEFIT Investigators. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J 156 (2008) 37-43
116. Scanavacca M.I., Sosa E.A., Lee J.H., et al. Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia. Arq Bras Cardiol 54 (1990) 367-371 (in Portuguese).
117. Scanavacca M.I., de Brito F.S., Maia I., et al. Sociedade Brasileira de Cardiologia. Guidelines for the evaluation and treatment of patients with cardiac arrhythmias. Arq Bras Cardiol 79 suppl 5 (2002) 1-50 (in Portuguese).
118. Garillo R., Greco O.T., Oseroff O., et al. Cardioverter defibrillator implantable as a secondary prevention in the Chagas' disease. The results of the Latin-American Studies ICD LABOR. Reblampa 17 (2004) 169-177 (in Spanish).
119. Rassi Jr. A. Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial. J Cardiovasc Electrophysiol 18 (2007) 1241-1243
120. Cardinalli-Neto A., Bestetti R.B., Cordeiro J.A., and Rodrigues V.C. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 18 (2007) 1236-1240
121. Sosa E., Scanavacca M., D'Avila A., et al. Radiofrequency catheter ablation of ventricular tachycardia guided by nonsurgical epicardial mapping in chronic Chagasic heart disease. Pacing Clin Electrophysiol 22 (1999) 128-130
122. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation 112 (2005) e154-e235
123. Quiros F.R., Morillo C.A., Casas J.P., et al. CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy (NCT00323973). Trials 7 (2006) 21
124. Bocchi E.A., and Fiorelli A. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. Ann Thorac Surg 71 (2001) 1833-1838
125. Campos S.V., Strabelli T.M., Amato Neto V., et al. Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant 27 (2008) 597-602
126. Tura B.R., Martino H.F., Gowdak L.H., et al. Multicenter randomized trial of cell therapy in cardiopathies-MiHeart Study. Trials 8 (2007) 2
127. Herbella F.A., Aquino J.L., Stefani-Nakano S., et al. Treatment of achalasia: lessons learned with Chagas' disease. Dis Esophagus 21 (2008) 461-467
128. Garcia R.L., Matos B.M., Féres O., and Rocha J.J. Surgical treatment of Chagas megacolon. Critical analysis of outcome in operative methods. Acta Cir Bras 23 suppl 1 (2008) 83-92
129. Coura J.R., and Dias J.C.P. Epidemiology, control and surveillance of Chagas disease-100 years after its discovery. Mem Inst Oswaldo Cruz 104 suppl 1 (2009) 31-40
130. Rassi Jr. A., Dias J.C., Marin-Neto J.A., and Rassi A. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease. Heart 95 (2009) 524-534
131. Médecins Sans Frontières. International meeting: new diagnostic tests are urgently needed to treat patients with Chagas disease. Rev Soc Bras Med Trop 41 (2008) 315-319
132. Rochitte C.E., Nacif M.S., de Oliveira Júnior A.C., et al. Cardiac magnetic resonance in Chagas' disease. Artif Organs 31 (2007) 259-267